TINA-QUANT IGM GEN.2 03507041190

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-03-16 for TINA-QUANT IGM GEN.2 03507041190 manufactured by Roche Diagnostics.

Event Text Entries

[40782450] This event occurred in (b)(6). (b)(4).
Patient Sequence No: 1, Text Type: N, H10


[40782451] The customer has described that they have received questionable results for a total of 18 patient samples tested with tina-quant igm gen. 2 (igm) on a p module. With these patient samples, the customer performed a comparison between the standard application of igm and the sensitive application of igm. Both standard and sensitive applications use the same reagent and the same calibrator. It was determined that patient and control results from the sensitive application are consistently lower than results from the standard application. It was noted that both applications showed good linearity, but agreement between the two applications is poor. Of the 18 patient samples, 16 had results that were erroneous. It was asked, but it is not known if any erroneous results were reported outside of the laboratory. Refer to the attachment for the patient result data. It was asked, but it is not known if any patients were adversely affected. The p module serial number was (b)(4). Based on results from the study, the customer states that the data suggests there may be an issue with assignment of calibrator concentration for the assay.
Patient Sequence No: 1, Text Type: D, B5


[43349699] Investigations have determined that recovery with the complained reagent and calibrator lot combination is within specifications. A specific root cause could not be determined for the issue experienced by the customer. Additional information required for the investigation was requested, but not provided.
Patient Sequence No: 1, Text Type: N, H10


[44898136] It has been confirmed that the erroneous results were not reported outside of the laboratory and that there were no adverse events related to this event.
Patient Sequence No: 1, Text Type: N, H10


MAUDE Entry Details

Report Number1823260-2016-00307
MDR Report Key5504728
Date Received2016-03-16
Date of Report2016-05-10
Date of Event2016-02-16
Date Mfgr Received2016-02-17
Date Added to Maude2016-03-16
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactNA MICHAEL LESLIE
Manufacturer Street9115 HAGUE ROAD NA
Manufacturer CityINDIANAPOLIS IN 46250
Manufacturer CountryUS
Manufacturer Postal46250
Manufacturer Phone3175214343
Manufacturer G1ROCHE DIAGNOSTICS GMBH
Manufacturer StreetSANDHOFERSTRASSE 116 NA
Manufacturer CityMANNHEIM (BADEN-WURTTEMBERG) 68305
Manufacturer CountryGM
Manufacturer Postal Code68305
Single Use3
Previous Use Code3
Removal Correction NumberNA
Event Type3
Type of Report3

Device Details

Brand NameTINA-QUANT IGM GEN.2
Generic NameIGM (MU CHAIN SPECIFIC), ANTIGEN, ANTISERUM, CONTROL
Product CodeDAO
Date Received2016-03-16
Model NumberNA
Catalog Number03507041190
Lot Number610334
ID NumberNA
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrR
Device Sequence No1
Device Event Key0
ManufacturerROCHE DIAGNOSTICS
Manufacturer Address9115 HAGUE ROAD NA INDIANAPOLIS IN 462500457 US 462500457


Patients

Patient NumberTreatmentOutcomeDate
10 2016-03-16

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.